Abstract
Background
Despite compelling links between excess body weight and cancer, body mass index (BMI) cut-points, or thresholds above which cancer incidence increased, have not been identified. The objective of this study was to determine if BMI cut-points exist for 14 obesity-related cancers.
Subjects/methods
In this retrospective cohort study, patients 18–75 years old were included if they had ≥2 clinical encounters with BMI measurements in the electronic health record (EHR) at a single academic medical center from 2008 to 2018. Patients who were pregnant, had a history of cancer, or had undergone bariatric surgery were excluded. Adjusted logistic regression was performed to identify cancers that were associated with increasing BMI. For those cancers, BMI cut-points were calculated using adjusted quantile regression for cancer incidence at 80% sensitivity. Logistic and quantile regression models were adjusted for age, sex, race/ethnicity, and smoking status.
Results
A total of 7079 cancer patients (mean age 58.5 years, mean BMI 30.5 kg/m2) and 270,441 non-cancer patients (mean age 43.8 years, mean BMI 28.8 kg/m2) were included in the study. In adjusted logistic regression analyses, statistically significant associations were identified between increasing BMI and the incidence of kidney, thyroid, and uterine cancer. BMI cut-points were identified for kidney (26.3 kg/m2) and uterine (26.9 kg/m2) cancer.
Conclusions
BMI cut-points that accurately predicted development kidney and uterine cancer occurred in the overweight category. Analysis of multi-institutional EHR data may help determine if these relationships are generalizable to other health care settings. If they are, incorporation of BMI into the screening algorithms for these cancers may be warranted.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
$39.95
Prices may be subject to local taxes which are calculated during checkout




Data availability
Aggregated and de-identified data is available upon request. Those interested in acquiring the data will require a Data Transfer and Use Agreement (DTUA) for de-identified data between University of Wisconsin and the recipient. The form is available at https://rsp.wisc.edu/contracts/dtua.cfm under “DTUA forms.”
References
National Center for Health Statistics. National Health and Nutrition Examination Survey, 2017-2018 data: CDC. 2020. https://www.cdc.gov/nchs/data/factsheets/factsheet_nhanes.pdf. Accessed 2 Nov 2020.
National Center for Health Statistics. Obesity and Overweight: CDC. 2018. https://www.cdc.gov/nchs/fastats/obesity-overweight.htm. Accessed 2 Nov 2020.
Choi EK, Park HB, Lee KH, Park JH, Eisenhut M, van der Vliet HJ, et al. Body mass index and 20 specific cancers: re-analyses of dose-response meta-analyses of observational studies. Ann Oncol. 2018;29:749–57.
Keum N, Greenwood DC, Lee DH, Kim R, Aune D, Ju W, et al. Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies. J Natl Cancer Inst. 2015;107:djv088.
Kyrgiou M, Kalliala I, Markozannes G, Gunter MJ, Paraskevaidis E, Gabra H, et al. Adiposity and cancer at major anatomical sites: umbrella review of the literature. BMJ. 2017;356:j477–j.
Lee K, Kruper L, Dieli-Conwright CM, Mortimer JE. The impact of obesity on breast cancer diagnosis and treatment. Curr Oncol Rep. 2019;21:41.
Allott EH, Masko EM, Freedland SJ. Obesity and prostate cancer: weighing the evidence. Eur Urol. 2013;63:800–9.
Lauby-Secretan B, Scoccianti C, Loomis D, Grosse Y, Bianchini F, Straif K. Body fatness and cancer-viewpoint of the IARC Working Group. N Engl J Med. 2016;375:794–8.
Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med. 2003;348:1625–38.
Kolb R, Sutterwala FS, Zhang W. Obesity and cancer: inflammation bridges the two. Curr Opin Pharmacol. 2016;29:77–89.
American Cancer Society. Cancer Facts & Figures. Atlanta: ACS. 2020. https://www.cancer.org/content/dam/cancer-org/research/cancer-facts-and-statistics/annual-cancer-facts-and-figures/2020/cancer-facts-and-figures-2020.pdf. Accessed 2 Nov 2020.
Ligibel JA, Alfano CM, Courneya KS, Demark-Wahnefried W, Burger RA, Chlebowski RT, et al. American Society of Clinical Oncology position statement on obesity and cancer. J Clin Oncol. 2014;32:3568–74.
Rock CL, Doyle C, Demark-Wahnefried W, Meyerhardt J, Courneya KS, Schwartz AL, et al. Nutrition and physical activity guidelines for cancer survivors. CA Cancer J Clin. 2012;62:243–74.
Senkus E, Kyriakides S, Penault-Llorca F, Poortmans P, Thompson A, Zackrisson S, et al. Primary breast cancer: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2013;24:vi7–23.
Liu N, Birstler J, Hanlon B, Funk LM. BMI and chronic health conditions: where are the tipping points? J Med Internet Res. 2021;23:e24017.
Chu FL, Hsu CH, Jeng C. Lowered cutoff points of obesity indicators are better predictors of hypertension and diabetes mellitus in premenopausal Taiwanese women. Obes Res Clin Pract. 2015;9:328–35.
Mascie-Taylor CGN, Goto R. Human variation and body mass index: a review of the universality of BMI cut-offs, gender and urban-rural differences, and secular changes. J Physiol Anthropol. 2007;26:109–12.
Jih J, Mukherjea A, Vittinghoff E, Nguyen TT, Tsoh JY, Fukuoka Y, et al. Using appropriate body mass index cut points for overweight and obesity among Asian Americans. Prev Med. 2014;65:1–6.
Von Elm E, Altman DG, Egger M, Pocock SJ, Gøtzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. J Clin Epidemiol. 2008;61:344–9.
Cheng FW, Gao X, Mitchell DC, Wood C, Still CD, Rolston D, et al. Body mass index and all-cause mortality among older adults. Obesity. 2016;24:2232–9.
Centers for Medicare and Medicaid Services (CMS). Chronic Conditions Data Warehouse 2021. https://www2.ccwdata.org/web/guest/condition-categories. Accessed 20 June 20 2021.
Vittinghoff E, McCulloch CE. Relaxing the rule of ten events per variable in logistic and Cox regression. Am J Epidemiol. 2007;165:710–8.
Koenker R, Hallock KF. Quantile Regression. J Econ Perspect. 2001;15:143–56.
Araneta MRG, Kanaya AM, Hsu WC, Chang HK, Grandinetti A, Boyko EJ, et al. Optimum BMI cut points to screen Asian Americans for type 2 diabetes. Diabetes Care. 2015;38:814–20.
Wood S. Generalized additive models: an introduction with R. Second ed. New York: Chapman & Hall/CRC; 2006.
Sollberger TL, Gavrilyuk O, Rylander C. Excess body weight and incidence of type 1 and type 2 endometrial cancer: the Norwegian Women and Cancer Study. Clin Epidemiol. 2020;12:815–24.
Haggerty AF, Sarwer DB, Schmitz KH, Ko EM, Allison KC, Chu CS. Obesity and endometrial cancer: a lack of knowledge but opportunity for intervention. Nutr Cancer. 2017;69:990–5.
Onstad MA, Schmandt RE, Lu KH. Addressing the role of obesity in endometrial cancer risk, prevention, and treatment. J Clin Oncol. 2016;34:4225–30.
World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Report 2018. Food: Nutrition, Physical Activity, and the Prevention of Endometrial Cancer. dietandcancerreport.org. Accessed 2 Nov 2020.
Wang F, Xu Y. Body mass index and risk of renal cell cancer: a dose-response meta-analysis of published cohort studies. Int J Cancer. 2014;135:1673–86.
World Cancer Research Fund/American Institute for Cancer Research. Continuous Update Project Expert Report 2018. Diet, nutrition, physical activity and kidney cancer. dietandcancerreport.org. Accessed 2 Nov 2020.
Pischon T, Lahmann PH, Boeing H, Tjønneland A, Halkjaer J, Overvad K, et al. Body size and risk of renal cell carcinoma in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer. 2006;118:728–38.
Nam GE, Cho KH, Han K, Kim CM, Han B, Cho SJ, et al. Obesity, abdominal obesity and subsequent risk of kidney cancer: a cohort study of 23.3 million East Asians. Br J Cancer. 2019;121:271–7.
Hunt JD, van der Hel OL, McMillan GP, Boffetta P, Brennan P. Renal cell carcinoma in relation to cigarette smoking: meta-analysis of 24 studies. Int J Cancer. 2005;114:101–8.
Setiawan VW, Stram DO, Nomura AM, Kolonel LN, Henderson BE. Risk factors for renal cell cancer: the multiethnic cohort. Am J Epidemiol. 2007;166:932–40.
Guh DP, Zhang W, Bansback N, Amarsi Z, Birmingham CL, Anis AH. The incidence of co-morbidities related to obesity and overweight: A systematic review and meta-analysis. BMC Public Health. 2009;9:88.
Wise LA, Palmer JR, Spiegelman D, Harlow BL, Stewart EA, Adams-Campbell LL, et al. Influence of body size and body fat distribution on risk of uterine leiomyomata in U.S. black women. Epidemiology. 2005;16:346–54.
Stafford HS, Saltzstein SL, Shimasaki S, Sanders C, Downs TM, Sadler GR. Racial/ethnic and gender disparities in renal cell carcinoma incidence and survival. J Urol. 2008;179:1704–8.
WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. Lancet. 2004;363:157–63.
Pleijhuis RG, Kwast AB, Jansen L, de Vries J, Lanting R, Bart J, et al. A validated web-based nomogram for predicting positive surgical margins following breast-conserving surgery as a preoperative tool for clinical decision-making. Breast. 2013;22:773–9.
Pereira-Azevedo N, Osório L, Fraga A, Roobol MJ. Rotterdam prostate cancer risk calculator: development and usability testing of the mobile phone app. JMIR Cancer. 2017;3:e1–e.
Zhang JX, Song W, Chen ZH, Wei JH, Liao YJ, Lei J, et al. Prognostic and predictive value of a microRNA signature in stage II colon cancer: a microRNA expression analysis. Lancet Oncol. 2013;14:1295–306.
Yang L, Takimoto T, Fujimoto J. Prognostic model for predicting overall survival in children and adolescents with rhabdomyosarcoma. BMC Cancer. 2014;14:654.
Feng LH, Su T, Bu KP, Ren S, Yang Z, Deng CE, et al. A clinical prediction nomogram to assess risk of colorectal cancer among patients with type 2 diabetes. Sci Rep. 2020;10:14359.
Liu A, Wang Z, Yang Y, Wang J, Dai X, Wang L, et al. Preoperative diagnosis of malignant pulmonary nodules in lung cancer screening with a radiomics nomogram. Cancer Commun. 2020;40:16–24.
Chung JW, Jang ES, Kim J, Jeong S-H, Kim N, Lee DH, et al. Development of a nomogram for screening of hepatitis B virus-associated hepatocellular carcinoma. Oncotarget. 2017;8:106499–510.
PDQ® Screening and Prevention Editorial Board. PDQ Endometrial Cancer Screening Bethesda, MD: National Cancer Institute. https://www.cancer.gov/types/uterine/hp/endometrial-screening-pdq. Accessed December 13, 2021.
Muinelo-Romay L, Casas-Arozamena C, Abal M. Liquid biopsy in endometrial cancer: new opportunities for personalized oncology. Int J Mol Sci. 2018;19:2311. https://doi.org/10.3390/ijms19082311.
Escudier B, Porta C, Schmidinger M, Rioux-Leclercq N, Bex A, Khoo V, et al. Renal cell carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up. Ann Oncol. 2019;30:706–20.
Rossi SH, Klatte T, Usher-Smith J, Stewart GD. Epidemiology and screening for renal cancer. World J Urol. 2018;36:1341–53.
Soliman PT, Bassett RL Jr., Wilson EB, Boyd-Rogers S, Schmeler KM, Milam MR, et al. Limited public knowledge of obesity and endometrial cancer risk: what women know. Obstet Gynecol. 2008;112:835–42.
Funding
Effort on this study and manuscript was made possible by an American College of Surgeons George H.A. Clowes Career Development Award and a VA Career Development Award to LMF (CDA 015–060). The views in this study represent those of the authors and not those of the Department of Veterans Affairs or the U.S. Government. The project was also supported by the Clinical and Translational Science Award (CTSA) program, through the National Institutes of Health (NIH) National Center for Advancing Translational Sciences (NCATS) (grant UL1TR002373). Further funding was through the NIH T32 Surgical Oncology Research Training Program (grant CA090217–17) and the NIH Metabolism and Nutrition Training Program T32 (grant DK 007665).
Author information
Authors and Affiliations
Contributions
NL, JB, BMH, MV, LPH, and LMF contributed to study design. JAM, NL, JB, BMH, MV, and LMF contributed to data collection and analysis. JAM, NL, JB, and LMF contributed to manuscript composition. All co-authors participated in the data interpretation and manuscript revisions. All co-authors approved the version to be published and agreed to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work were appropriately investigated and resolved.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Additional information
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary information
Rights and permissions
About this article
Cite this article
Murtha, J.A., Liu, N., Birstler, J. et al. Obesity and “obesity-related” cancers: are there body mass index cut-points?. Int J Obes 46, 1770–1777 (2022). https://doi.org/10.1038/s41366-022-01178-0
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41366-022-01178-0